Gilead Sciences (NASDAQ:GILD) Given New $95.00 Price Target at Barclays
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective raised by Barclays from $84.00 to $95.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has an equal weight rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the company. Sanford C. Bernstein started coverage on […]
More Stories
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Plus Therapeutics (NASDAQ:PSTV) Financial Comparison
Plus Therapeutics (NASDAQ:PSTV – Get Free Report) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN – Get Free Report) are both small-cap...
Massimo Group (NASDAQ:MAMO) Trading Up 4% – What’s Next?
Shares of Massimo Group (NASDAQ:MAMO – Get Free Report) were up 4% on Wednesday . The company traded as high...
AlTi Global (NASDAQ:ALTI) Share Price Crosses Above 200-Day Moving Average – What’s Next?
AlTi Global, Inc. (NASDAQ:ALTI – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday...
AVEVA Group (LON:AVV) Shares Cross Above 200-Day Moving Average – Here’s What Happened
AVEVA Group plc (LON:AVV – Get Free Report)’s share price crossed above its two hundred day moving average during trading...
Culp (NYSE:CULP) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?
Culp, Inc. (NYSE:CULP – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The...
THG Plc (OTCMKTS:THGPF) Short Interest Update
THG Plc (OTCMKTS:THGPF – Get Free Report) was the target of a significant increase in short interest in October. As...